Investigational Site Number : 3920011

Sapporo, Hokkaido 063-0841

1 studies enrolling now · 2 studies all time

What they study most

Immunoglobulin G4 Related Disease, RSV Immunisation

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers — Stopped early